ANTONIA GARNER: Open Payments
NPI 1992130132 · TEMPLETON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 48 payments from 17 companies in 2025. Trend: 2023 $1,194 · 2024 $994 · 2025 $1,008
Food & beverage: $941Education: $67
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $222 |
| ABBVIE INC. | 11 | $211 |
| Arcutis Biotherapeutics, Inc. | 3 | $77 |
| Organon LLC | 3 | $62 |
| Incyte Corporation | 2 | $56 |
| UCB, Inc. | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| Lilly USA, LLC | 2 | $45 |
| Biofrontera Inc. | 2 | $44 |
| Organogenesis Inc. | 1 | $40 |
Products named: TREMFYA, SKYRIZI, Zoryve, RINVOQ, OPZELURA, Bimzelx, Sotyktu, TALTZ.
Industry payments across CA — which companies pay providers there.
